IntroductionTotal hip arthroplasty (THA) is a procedure that aims to restore the function of the hip joint. Diabetes mellitus (DM) is one of the most prevalent comorbidities among patients undergoing THA. DM involves various immunological and metabolic aspects, which lead to limitations and surgical complications.ObjectiveTo evaluate the association between THA complications and controlled DM during hospitalization period.MethodsCross-sectional research through the analysis of retrospective records of a private hospital in Salvador, Bahia. The chi-squared and Fisher's exact tests were used in SAS statistical program.ResultsMost patients were elderly females. The most prevalent comorbidities in the sample were hypertension and diabetes. The most frequent underlying pathology in the sample was coxarthrosis; among patients with DM, it was femoral neck fracture. The most common complications were changes in the hemolymphopoietic system, among which anemia was the most frequent complication. Cardiovascular, nervous, and blood glucose complications were positively associated with controlled DM. In turn, hemolymphopoietic, genitourinary, digestive, electrolyte, and infectious complications were not associated with DM. Having DM was a protective factor for thermal complications. There was no statistically significant difference between patients that had or did not have DM in each complication group studied.ConclusionPatients with controlled DM did not present more complications than those without DM during hospitalization in the post THA.
Objective: Describe the clinical and epidemiological profile of patients undergoing total hip arthroplasty by analyzing the correlations between gender and indication of surgery and postoperative complications.
Methods:Cross-sectional study in retrospective approach of the medical records of patients undergoing total hip arthroplasty in a private Hospital in Salvador, Bahia in 2013 and 2014.Results: 66, 3% of patients are women, aged between 71 and 80 years (31, 2%), systemic arterial hypertension patients (63, 9%), whose major indication occurred coxarthrosis (48, 2%) followed by hip fracture (39, 8%); mostly by falling from height (66, 7%). Among the complications, anemia prevailed (53%) and death occurred in only 2, 4%. By correlating sex with indication of arthroplasty, hip fracture was only statistically significant in women (p=0.004); in complications, anemia (p=0.024) and urinary tract infection (p=0.025) had statistically significance in women and in men genitourinary changes (p<0.001).
Conclusions:Patients undergoing hip arthroplasty are elderly, female, hypertensive, most of whose procedures ran from coxarthrosis or hip fracture. Among the complications prevailed anemia, genitourinary, cardiovascular and digestive changes. Hip fracture, anemia and urinary tract infection are significantly more prevalent in females, while the genitourinary changes are significant in males.
ResumoIntrodução: artroplastia total de quadril (ATQ) é uma cirurgia que visa restabelecer a função da articulação coxofemoral, neste procedimento, a anemia é uma das complicações mais prevalentes. Objetivo: descrever as associações entre a anemia e as variáveis sociais e clínicas dos pacientes no perioperatório da ATQ em um hospital particular localizado em Salvador, Bahia. Resultados: a maioria dos pacientes era do sexo feminino e idoso. A comorbidade mais prevalente foi hipertensão arterial sistêmica (HAS). A complicação mais comum pós cirurgia foi anemia. Houve associação da ATQ com a anemia com gênero, dislipidemia, transfusão sanguínea, tempo de internação hospitalar total e número de bolsas de sangue utilizadas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.